Wegovy video instructions: watching before you inject is worth the ten minutes

Why the video matters before your first pen

Reading a leaflet and watching someone demonstrate are two different things. Injection technique is one of those areas where even a confident, capable person can hesitate when they first hold the pen. That hesitation is completely normal, and it is exactly what the official Wegovy instructions video is designed to resolve.

Novo Nordisk's technique videos walk through every step at a pace you can pause and rewind: removing the pen cap, attaching the needle, checking the liquid is clear and colourless, priming, choosing your site, the 90-degree angle, the ten-second hold, and safe disposal of the needle. Each of those steps exists for a reason, and seeing them performed correctly once tends to settle the nerves more than any written description.

For a broader written companion to the video, our Wegovy injection instructions page covers the same sequence in text form, which is useful if you want to check a specific step quickly mid-process. The two formats complement each other rather than duplicate.

One practical note: the video will reference needle disposal. In the UK, used needles go into an approved sharps container, not a household bin. Your prescriber or pharmacist can advise on local disposal routes.

Deciding which video source to trust

Search results for "Wegovy video instructions" turn up a mix of official manufacturer content, NHS explainers, and patient-made uploads of varying quality. The decision worth making early is which source you rely on.

The authoritative options are the Novo Nordisk UK patient video (wegovy.co.uk), the product's Patient Information Leaflet, and any video linked directly from the Wegovy how-to video resources we have collated for patients. These reflect the approved UK presentation of the pen. User-generated content may show an older pen format, a different dose device, or steps from another country's version of the product, the pen design matters because the priming and injection sequence can differ.

There is also a separate consideration if you are moving from the standard 2.4 mg weekly pen to the newer 7.2 mg single-dose pen, approved by the MHRA in April 2026. The device mechanics differ, and the manufacturer video for that pen is specific to it. If your prescriber has moved you to the higher dose, check that the video you are watching matches your actual pen.

Detailed guidance on the full Wegovy administration process, including site rotation and what counts as a missed dose, is covered in our dedicated administration page.

The three technique decisions the video helps you make

Beyond simply watching, the video helps you settle three practical choices that your prescriber sets the framework for but you carry out each week.

Where to inject. Abdomen, thigh, or upper arm are all licensed sites. The video demonstrates each. Most people find the abdomen easiest to reach, but if you have any skin condition, scarring or sensitivity at one site, the others are equally valid. The rule is not to use the same spot two weeks running.

How to hold the pen. Firm, flat contact, ninety degrees to the skin, no pressing the pen body down while the mechanism fires. The video makes this intuitive in a way that words alone rarely do. You can also find a companion written walkthrough on the Wegovy use video page if you want to cross-reference.

What to do when something looks wrong. The liquid should be clear and colourless; any cloudiness or particles means do not inject and contact your pharmacist. A pen that offers resistance mid-injection, or one that has been left out of the fridge for longer than the leaflet permits, needs the same response. The video covers normal appearance, learning that first makes the abnormal easier to spot.

For anything that sits outside those three decisions (timing adjustments, what to do after a missed dose, how long you continue treatment) your prescriber is the right person to ask. Downloadable patient instruction resources can help you note questions down before that conversation.

Context: Wegovy as a prescription medicine, and the route to starting

Wegovy (semaglutide) is licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition. It is a prescription-only medicine, which means a clinician reviews your health history before any pen is dispensed, the video comes after that step, not before it.

NHS access to Wegovy currently runs through specialist weight management services, as set out in NICE's technology appraisal TA875, and waiting times can be significant. Private prescribing through a regulated online pharmacy is the alternative for people who meet the clinical criteria but cannot wait. If you are considering a private prescription and want to spread the cost, our Wegovy Klarna page explains the pay-later options available at checkout. For a clear picture of how the costs compare and what a private prescription typically includes, the Wegovy price comparison page sets that out without the marketing gloss.

If you are weighing whether treatment is right for you, rather than simply looking for the video, our weight loss treatment overview covers what the evidence says, who Wegovy suits, and how it sits alongside lifestyle changes. When you are ready to take the next step, start your free consultation with our prescribers.